~~<i id='587DAEE825'><strike id='587DAEE825'><tt id='587DAEE825'><pre id='587DAEE825'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：entertainment 2025-08-28 08:40:22 - browse：279

Two Vertex buidings in the Seaport District — David L Ryan/Globe Staff

When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

Now, Vertex may be on the move again.

With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Roche to buy Carmot Therapeutics, developer of obesity drugs

knowledge

leisure time

explore

hotspot

AdobeMr.Kaneisusingonehandtoclutchtheplasticbasinintowhichheisvomitingandgesturinghellowiththeotherh

WSS

Leukemia patients are helped by Syndax's new type of therapy

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Pharma showers House GOP doctor with campaign cash

Pregnancy discrimination could be enabled by AI

When waiting feels immoral: Empathy in the emergency department

CDC recommends RSV monoclonal antibody for infants

focus

fashion

knowledge

As demand for Covid shots wanes, Moderna seeks its next success

Heart disease in astronauts blamed on cosmic radiation

Continuity nursing helped my family in our darkest PICU moments

A controversial new treatment promises to make little people taller

In Memoriam: Notable people who died in 2023

FDA approves world's first CRISPR

The cancer drug shortage isn’t new — and neither are the solutions

Congenital heart disease patients face new threat of heart failure

Bright Health sells Medicare Advantage business to Molina

SCOTUS to consider access to abortion pill mifepristone

knowledge

Spinal cord stimulation reduces pain in amputees, study finds

It costs an awful lot of money to give away a kidney

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Leukemia patients are helped by Syndax's new type of therapy

Biotech startup Celsius cuts 75% of staff ahead of first trial start

leisure time

explore

explore

hotspot